“…A meta-analysis found that rTMS is as effective as atypical antipsychotics (same NNT) in treatment-resistant depression (Gaynes et al 2014), while other meta-analysis suggested that rTMS has the same effi cacy of commonly available antidepressant drugs in depression (Schutter 2009). A recent meta-analysis suggested that ECT seems superior to rTMS, although the quality of the included studies was low (Ren et al 2014).…”
Peripheral BDNF levels do not increase after NIBS in depression. Such biomarker might, therefore, not be suitable to index NIBS antidepressant response. Further trials are needed, particularly exploring non-medicated populations, performing subsequent BDNF assessments in a larger timeframe and employing more intensive NIBS treatment protocols.
“…A meta-analysis found that rTMS is as effective as atypical antipsychotics (same NNT) in treatment-resistant depression (Gaynes et al 2014), while other meta-analysis suggested that rTMS has the same effi cacy of commonly available antidepressant drugs in depression (Schutter 2009). A recent meta-analysis suggested that ECT seems superior to rTMS, although the quality of the included studies was low (Ren et al 2014).…”
Peripheral BDNF levels do not increase after NIBS in depression. Such biomarker might, therefore, not be suitable to index NIBS antidepressant response. Further trials are needed, particularly exploring non-medicated populations, performing subsequent BDNF assessments in a larger timeframe and employing more intensive NIBS treatment protocols.
“…Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for medication-refractory major depressive disorder [1], yet the mechanisms of action for this intervention are poorly understood. Studies have shown that rTMS treatment for depression may be associated with changes in serum markers (e.g.…”
Background:
Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for medication-refractory major depression, yet the mechanisms of action for this intervention are poorly understood. Here we investigate cerebral cortex thickness as a possible biomarker of rTMS treatment response.
Methods:
Longitudinal change in cortical thickness is evaluated relative to clinical outcomes across 48 participants in 2 cohorts undergoing left dorsolateral prefrontal cortex rTMS as a treatment for depression.
Results:
Our results reveal changes in thickness in a region of the left rostral anterior cingulate cortex that correlate with clinical response, with this region becoming thicker in patients who respond favorably to rTMS and thinner in patients with a less favorable response. Moreover, the baseline cortical thickness in this region correlates with rTMS treatment response – those patients with thinner cortex before treatment tended to have the most clinical improvement.
Conclusions:
This study is the first analysis of longitudinal cortical thickness change with rTMS as a treatment for depression with similar results across two cohorts. These results support further investigation into the use of structural MRI as a possible biomarker of rTMS treatment response.
“…A systematic review revealed that rTMS is an effective antidepressant treatment for adolescents with resistant depression (Donaldson et al, 2014). Although studies have found that the effectiveness of rTMS for some patients with depression is not obvious (Couturier, 2005), several randomized, controlled trials have reported that rTMS is effective in the treatment of depression or treatment-resistant depression (Berlim et al, 2011;Gaynes et al, 2014). Animal research has revealed that chronic rTMS increases hippocampal neurogenesis in rats (Ueyama et al, 2011), and the exposure of C57BL/6 mice to low-frequency electromagnetic fields results in improvements in hippocampus neurogenesis (Cuccurazzu et al, 2010).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.